Blood test strategy aims to curb dangerous antibiotic overuse in hospitals
NCT ID NCT07211620
Summary
This study is testing if tracking how a blood marker called procalcitonin changes over time is better than using a single high reading to decide when to start antibiotics in intensive care patients with a suspected infection. It aims to reduce unnecessary antibiotic prescriptions, which can cause side effects and fuel drug-resistant superbugs. The trial will compare the safety and effectiveness of these two decision-making methods in 250 critically ill but stable patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Margaret's Hospital
NOT_YET_RECRUITINGBudapest, 1032, Hungary
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Semmelweis University, Department of Intensive Therapy
RECRUITINGBudapest, 1082, Hungary
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.